Diligence memo · auto-generated · as of July 2, 2026
Daymark Health, Inc.
Daymark Health, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Daymark Health, Inc. operates in Healthtech, based in Philadelphia.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Daymark Health, Inc. has raised $38M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $26M on 2025-08-19.
Most recent recorded round closed around 2025-08-19.
Valuation (modeled)modeled
Provath models Daymark Health, Inc. at approximately $122M (range $61M–$176M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.25× the median modeled value of Series B Healthtech companies in 2025–2027 (55 peers) — value vs value, same stage and era. Within the normal band (125% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 10 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 4.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 88% of Healthtech peers (2138 compared).
Modeled value ranks above 81% of those peers.
Closest niche peers: Sevaro Health Inc, Field Medical, Inc., Berry Street Health, Inc., Puzzle Medical Devices Inc., Cartwheel Care Inc..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.